Association of Therapeutic Adherence with Stress, Anxiety and Depression in Patients with Type 2 Diabetes
DOI:
https://doi.org/10.62514/amf.v27i2.134Keywords:
Type 2 diabetes, Therapeutic adherence, Stress, DepressionAbstract
Objective: To determine the association between therapeutic adherence and stress, anxiety, and depression in patients with type 2 diabetes. Methods: Cross-sectional and analytical study in adult patients with type 2 diabetes (DM2), who came to receive care at the Family Medicine Unit No. 16; the Morisky-Green test was applied to measure therapeutic adherence and the DASS-21 scale to measure the degree of stress, anxiety, and depression. Informed consent was obtained from the participants. Descriptive statistics and the χ² test were used using the statistical program SPSS v 23. Results: 157 patients were included, where poor therapeutic adherence was 61.8%. The frequency of anxiety was 26.8%, stress 19.8%, and depression11.5%. An association was only found between anxiety and therapeutic adherence (χ² 4.662, p=0.038). Conclusions: Poor therapeutic adherence and anxiety predominated in patients with DM2, finding an association between both variables; in stress and depression were not correlated..